Metreleptin Clinical Trials
5 recruitingDrug
Phase 32Phase 21Phase 41
Showing 1–5 of 5 trials
Recruiting
Phase 3
Open-label Extension Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy
Familial Partial Lipodystrophy
Amryt Pharma24 enrolled7 locationsNCT06679270
Recruiting
MEASuRE: Metreleptin Effectiveness And Safety Registry
Partial LipodystrophyGeneralised Lipodystrophy
Amryt Pharma100 enrolled28 locationsNCT02325674
Recruiting
Phase 3
Open-label Study to Evaluate Metreleptin in Children Under 6 Years of Age With Generalised Lipodystrophy
Generalized Lipodystrophy
Amryt Pharma15 enrolled12 locationsNCT06502990
Recruiting
Phase 2
Metreleptin in Anorexia Nervosa
Anorexia Nervosa
Gabriella Milos50 enrolled1 locationNCT06305182
Recruiting
Phase 4
Open-label Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy
Partial Lipodystrophy
Amryt Pharma12 enrolled12 locationsNCT06484868